ArticlePloS one2026
Rate of nicotine metabolism on risk of myocardial infarction among people with HIV who smoke cigarettes.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundThe prevalence of cigarette use in people with HIV (PWH) is 2-3 times higher than the general population. Cigarette use increases risk of myocardial infarction (MI). Faster nicotine metabolism, quantified by the nicotine metabolite ratio (NMR) is associated with greater risk for nicotine dependence and lung cancer, but its association with MI is unknown.
methodsWe conducted a nested case-control study within the Center for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort. Cases were PWH who reported cigarette use with incident adjudicated MI between 2003 and 2020 and available plasma samples; cigarette-smoking controls were selected by incidence density sampling, matched on age, race, birth sex, and plasma HIV RNA level. Conditional logistic regression was used to estimate odds ratios (OR) for the association of NMR and MI.
resultsWe identified 135 cases with MI and 252 controls. Median (IQR) NMR was greater in cases [0.51 (0.36, 0.73)] than in controls [0.47 (0.30, 0.70)]. In conditional logistic regression, the odds of having a high NMR were 1.4 times greater among MI cases than controls, but not at a statistically significant level (OR: 1.4, 95% CI: 0.97-1.9). This estimate did not substantively change after further adjustment for statin use, hypertension, and diabetes (OR: 1.4, 95% CI: 0.92-2.0).
conclusionsThere is a small-magnitude association between NMR and MI, which was not statistically significant. NMR remains a potential biomarker for MI risk among PWH. Further investigation is needed to estimate the precise effect of NMR on MI in PWH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.